Related Experiment Video

Updated: Jul 11, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Cetuximab is effective, but more toxic than reported in the Bonner trial

H K Lord, E Junor, J Ironside

    Clinical Oncology (Royal College of Radiologists (Great Britain))
    |October 12, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
    06:25

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

    Published on: June 14, 2021

    Related Experiment Videos

    Last Updated: Jul 11, 2026

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
    15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
    06:25

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

    Published on: June 14, 2021

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience.

    The Journal of laryngology and otology·2016

    No evidence of asymptomatic variant CJD infection in immunodeficiency patients treated with UK-sourced immunoglobulin.

    Vox sanguinis·2015

    Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.

    British journal of cancer·2011

    Chordoma masquerading as a nerve root tumour -- a clinical lesson.

    The British journal of radiology·2009

    Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.

    European journal of cancer (Oxford, England : 1990)·2009

    Fourth ventricle ependymoma in father and son.

    British journal of neurosurgery·2007

    Time Trends in Cardiac Doses in 10,000 Patients Receiving Curative Thoracic Radiation Therapy Between 2009 and 2020.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    A Regression Meta-Analysis for Myelopathy in Re-Irradiation of Non-Spinal Cord Tumours.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    The Leaky Pipeline Across Borders: A Cross-sectional Analysis of Gender Parity in Radiation Oncology in Austria and Switzerland.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Analysis of Lymphopenia in Patients with Stage III Non-small Cell Lung Cancer Treated with Chemoradiotherapy and Consolidation Immunotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    A Systematic Review and Meta-Analysis of the Prognostic Value of Tumor Response Measurements During Radiotherapy for Head and Neck cancers.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Definitive Stereotactic Body Radiotherapy for Unresectable Primary Bone and Soft Tissue Tumors: A Single-institution Experience.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us